Research & Strategy
Our research philosophy is built on deep industry expertise and a rigorous commitment to understanding target companies and their competitive landscapes.
Research & Strategy
Our research philosophy is built on deep industry expertise and a rigorous commitment to understanding target companies and their competitive landscapes.
Equity Research & Client Services
Our research team is composed of industry experts who combine investigative research with financial analysis. We provide comprehensive industry analysis, company coverage, and a wide range of services tailored to the needs of our institutional and corporate clients.
- Company Coverage Reports
- Industry Analysis & Trends
- Key Opinion Leader Events
- Company Road Shows
- Annual Conference
- Mini-Topical Conferences
- Industry Roundtables with Experts
Sector Expertise
Sector specialists are dedicated to long-term franchise growth. Our teams offer integrated financial advisory and capital markets services, along with in-depth sector expertise. Each team is exclusively focused on its specific area of specialization.
Our Experienced Team Transacts Across the Following Sectors:
Basic Materials
Consumer
Energy & Production
Financial Services
Healthcare
Industrials
REITs
Technology
Recent Transactions
December 11, 2025
Treasure Global Inc.
Nasdaq: TGL
$2,500,000
Registered Direct
Exclusive Placement Agent
December 5, 2025
New America Acquisition I Corp.
NYSE: NWAXU
$345,000,000
Initial Public Offering
Co-Lead Bookrunner
November 28, 2025
SC II Acquisition Corp.
Nasdaq: SCIIU
~$173,000,000
Initial Public Offering
Sole Bookrunner
November 20, 2025
Perplexity AI, Inc.
Perplexity AI Series Interests
~$5,500,000
Private Offering
Exclusive Placement Agent
November 11, 2025
Decent Holding Inc.
Nasdaq: DXST
~$8,000,000
Registered Follow-On
Exclusive Placement Agent
October 31, 2025
ECARX Holdings Inc.
Nasdaq: ECX
~$150,000,000
Registered Direct Offering
Exclusive Placement Agent
October 31, 2025
Vivakor, Inc.
Nasdaq: VIVK
~$2,500,000
Registered Direct Offering
Exclusive Placement Agent
October 29, 2025
XORTX Therapeutics Inc.
Nasdaq: XRTX
~$1,000,000
Registered Direct Offering
Exclusive Placement Agent
October 27, 2025
Undisclosed Healthcare Company
$18,000,000
Convertible Note
Financial Advisor
News & Insights
Stay up to date with the latest news, market commentary, and strategic insights from the team at D. Boral Capital.











